Elevated Urate Levels Do Not Alter Bone Turnover Markers: Randomized Controlled Trial of Inosine Supplementation in Postmenopausal Women.
Nicola DalbethAnne HorneBorislav MihovAngela StewartGregory D GambleTony Raymond MerrimanLisa K StampIan R ReidPublished in: Arthritis & rheumatology (Hoboken, N.J.) (2021)
This clinical trial shows that although inosine supplementation leads to sustained increases in serum urate levels over a 6-month period, it does not alter markers of bone turnover in postmenopausal women. These findings do not support the concept that urate has direct biologic effects on bone turnover.